Treace Medical Concepts Inc Asset Resilience Ratio
Treace Medical Concepts Inc asset resilience ratio. Treace Medical Concepts Inc (TMCI) has an Asset Resilience Ratio of 22.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Treace Medical Concepts Inc fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Treace Medical Concepts Inc (2021–2025)
Asset resilience ratio of Treace Medical Concepts Inc from 2021 to 2025. This chart shows how Treace Medical Concepts Inc's Asset Resilience Ratio has changed over time. Read TMCI liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Treace Medical Concepts Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see TMCI total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.31 Million | 22.98% |
| Total Liquid Assets | $42.31 Million | 22.98% |
Asset Resilience Insights
- Good Liquidity Position: Treace Medical Concepts Inc maintains a healthy 22.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Treace Medical Concepts Inc Industry Peers by Asset Resilience Ratio
Compare Treace Medical Concepts Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Treace Medical Concepts Inc Asset Resilience Ratio by Year (2021–2025)
Treace Medical Concepts Inc asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Treace Medical Concepts Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.76% | $37.66 Million | $190.58 Million | -9.87pp |
| 2024-12-31 | 29.63% | $64.33 Million | $217.09 Million | -14.12pp |
| 2023-12-31 | 43.75% | $110.22 Million | $251.91 Million | +4.90pp |
| 2022-12-31 | 38.85% | $61.78 Million | $159.02 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $140.82 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more